PLoS ONE (Jan 2019)

Correction: Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study.

  • Satoshi Motoya,
  • Kenji Watanabe,
  • Haruhiko Ogata,
  • Takanori Kanai,
  • Toshiyuki Matsui,
  • Yasuo Suzuki,
  • Mitsuhiro Shikamura,
  • Kenkichi Sugiura,
  • Kazunori Oda,
  • Tetsuharu Hori,
  • Takahiro Araki,
  • Mamoru Watanabe,
  • Toshifumi Hibi

DOI
https://doi.org/10.1371/journal.pone.0215491
Journal volume & issue
Vol. 14, no. 4
p. e0215491

Abstract

Read online

[This corrects the article DOI: 10.1371/journal.pone.0212989.].